Polaryx Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -1,380 | -2,544 | -1,495 | -1,430 |
Net Income | -1,380 | -2,544 | -1,495 | -1,430 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,369 | -2,063 | -1,490 | -887 |
Cash | 11,542 | 3,080 | 5,143 | 5,745 |
Basic Shares | 48,278 | 47,219 | 47,343 | 189,372 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | -8,985 | -30,356 | -3,779 |
Net Income | -8,985 | -30,356 | -3,779 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -3,944 | -2,573 | -173 |
Cash | 5,143 | 4,621 | 2 |
Basic Shares | 47,343 | 189,372 | 189,372 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.03 |
2026-03-31 | -$0.05 |
2025-12-31 | -$0.16 |